Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Eichenfield

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Pediatric Dermatology|February 16, 2007
Evaluation of adrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisone butyrate 0.1% in treating children with atopic dermatitisLawrence Eichenfield, Charles N Ellis, David Fivenson, et al.
Journal of the American Academy of Dermatology|April 30, 2020
Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgarisLawrence Eichenfield, Adelaide Hebert, Linda Stein Gold, et al.
Cutis|March 31, 2010
Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mgLinda Stein Gold, Alma Cruz, Lawrence Eichenfield, et al.
Pediatric Dermatology|June 21, 2023
Assessment of the American Academy of Dermatology diagnostic criteria for pediatric atopic dermatitis and modification into a checkbox form: A cross-sectional studyJeremy Udkoff, Jenna Borok, Florin Vaida, et al.
Journal of the American Academy of Dermatology|September 25, 2002
Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infectionsAlan B Fleischer, Mark Ling, Lawrence Eichenfield, et al.
Journal of Drugs in Dermatology : JDD|August 3, 2007
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgarisJoel Schlessinger, Alan Menter, Michael Gold, et al.
Cutis|September 12, 2009
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxideDiane Thiboutot, Lawrence Eichenfield, Alan Shalita, et al.
Pediatric Dermatology|January 18, 2024
Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patientsAlexis Tracy, Lauren Loop, Safiyyah Bhatti, et al.
Journal of Drugs in Dermatology : JDD|June 24, 2020
Consensus on Neonatal Through Preadolescent AcneLawrence A. Schachner, Lawrence Eichenfield, Anneke Andriessen, et al.
Journal of the American Academy of Dermatology|July 28, 2007
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled studyDiane M Thiboutot, Jonathan Weiss, Alicia Bucko, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Pediatric Dermatology|February 16, 2007
Evaluation of adrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisone butyrate 0.1% in treating children with atopic dermatitisLawrence Eichenfield, Charles N Ellis, David Fivenson, et al.
Journal of the American Academy of Dermatology|April 30, 2020
Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgarisLawrence Eichenfield, Adelaide Hebert, Linda Stein Gold, et al.
Cutis|March 31, 2010
Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mgLinda Stein Gold, Alma Cruz, Lawrence Eichenfield, et al.
Pediatric Dermatology|June 21, 2023
Assessment of the American Academy of Dermatology diagnostic criteria for pediatric atopic dermatitis and modification into a checkbox form: A cross-sectional studyJeremy Udkoff, Jenna Borok, Florin Vaida, et al.
Journal of the American Academy of Dermatology|September 25, 2002
Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infectionsAlan B Fleischer, Mark Ling, Lawrence Eichenfield, et al.
Journal of Drugs in Dermatology : JDD|August 3, 2007
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgarisJoel Schlessinger, Alan Menter, Michael Gold, et al.
Cutis|September 12, 2009
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxideDiane Thiboutot, Lawrence Eichenfield, Alan Shalita, et al.
Pediatric Dermatology|January 18, 2024
Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patientsAlexis Tracy, Lauren Loop, Safiyyah Bhatti, et al.
Journal of Drugs in Dermatology : JDD|June 24, 2020
Consensus on Neonatal Through Preadolescent AcneLawrence A. Schachner, Lawrence Eichenfield, Anneke Andriessen, et al.
Journal of the American Academy of Dermatology|July 28, 2007
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled studyDiane M Thiboutot, Jonathan Weiss, Alicia Bucko, et al.
Pageof 6